trh

D. melanogaster

trachealess

What the model saw

Gene: trh
Organism: Drosophila melanogaster
Known functions: trachealess. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. RNA polymerase II transcription regulatory region sequence-specific DNA binding. protein dimerization activity. protein heterodimerization activity. sequence-specific DNA binding.

View unredacted entry

trachealess. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. RNA polymerase II transcription regulatory region sequence-specific DNA binding. protein dimerization activity. protein heterodimerization activity. sequence-specific DNA binding.

Solver output

Predicted influence

Unclear

Confidence

35%

Mechanism

Unclear

Reasoning

The trh (trachealess) gene encodes a bHLH-PAS transcription factor that acts as an RNA Pol II-specific transcriptional activator, primarily known for its role in tracheal system development in Drosophila through heterodimerization with partners like Tango (the ARNT homolog). While transcription factors in the bHLH-PAS family (e.g., HIF-1α homologs) are well-linked to aging via hypoxia/oxygen sensing and metabolic regulation, trh's primary characterized role is in developmental patterning of the tracheal system rather than in post-developmental longevity pathways. Its sequence-specific DNA binding and heterodimerization activity could theoretically influence nutrient sensing or stress response pathways, but there is insufficient functional evidence to confidently assign a pro- or anti-longevity role based solely on these molecular function annotations.

Key pathways

bHLH-PAS transcription factor signalingtracheal system developmentRNA polymerase II transcriptional regulation

Longevity influence

Anti-longevity

Lifespan effect

Increase

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer

✗Incorrect

Mechanism

✗Incorrect

Reasoning quality

2/5

Failure mode

Appropriately uncertain

Notes

The model predicted "unclear" with low confidence (0.35), while the ground truth is "anti_longevity." The model correctly identified trh as a bHLH-PAS transcription factor involved in tracheal development and noted its heterodimerization activity, but failed to connect these features to a longevity influence. The model's reasoning that there is "insufficient functional evidence" to assign a pro- or anti-longevity role is incorrect given that GenAge has classified it as anti_longevity. The model's uncertainty was somewhat reasonable given the limited information provided, but it missed the opportunity to reason about how tracheal system development and oxygen/hypoxia sensing (via bHLH-PAS factors) could relate to aging. The mechanistic reasoning was incomplete and did not arrive at the correct conclusion.

Raw API responses

solver

{
  "reasoning": "The trh (trachealess) gene encodes a bHLH-PAS transcription factor that acts as an RNA Pol II-specific transcriptional activator, primarily known for its role in tracheal system development in Drosophila through heterodimerization with partners like Tango (the ARNT homolog). While transcription factors in the bHLH-PAS family (e.g., HIF-1α homologs) are well-linked to aging via hypoxia/oxygen sensing and metabolic regulation, trh's primary characterized role is in developmental patterning of the tracheal system rather than in post-developmental longevity pathways. Its sequence-specific DNA binding and heterodimerization activity could theoretically influence nutrient sensing or stress response pathways, but there is insufficient functional evidence to confidently assign a pro- or anti-longevity role based solely on these molecular function annotations.",
  "confidence": 0.35,
  "key_pathways": [
    "bHLH-PAS transcription factor signaling",
    "tracheal system development",
    "RNA polymerase II transcriptional regulation"
  ],
  "mechanism_class": "unclear",
  "longevity_influence": "unclear"
}

advisor

{
  "notes": "The model predicted \"unclear\" with low confidence (0.35), while the ground truth is \"anti_longevity.\" The model correctly identified trh as a bHLH-PAS transcription factor involved in tracheal development and noted its heterodimerization activity, but failed to connect these features to a longevity influence. The model's reasoning that there is \"insufficient functional evidence\" to assign a pro- or anti-longevity role is incorrect given that GenAge has classified it as anti_longevity. The model's uncertainty was somewhat reasonable given the limited information provided, but it missed the opportunity to reason about how tracheal system development and oxygen/hypoxia sensing (via bHLH-PAS factors) could relate to aging. The mechanistic reasoning was incomplete and did not arrive at the correct conclusion.",
  "failure_mode": "appropriately_uncertain",
  "answer_correct": false,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}